Patent · US Active

Humanized antibodies against iRHOM2

US12404345B2 · kind B2 · utility

0Cited by

8References

24Claims

0Family size

Assignees

SciRhom GmbH · DE
NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY · US

Inventors

Matthias Schneider · Dossenheim, DE
Jens Ruhe · Martinsried, DE
Gisela Weskamp · New York, US
Carl Blobel · New York, US

Key dates

Filing date	Dec 19, 2024
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Dec 19, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to humanized antibodies or target-binding fragments or derivatives thereof retaining target binding capacities, which bind to human iRhom2 (FIG. 1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.